» Articles » PMID: 33545219

Maintaining Manganese in Tumor to Activate CGAS-STING Pathway Evokes a Robust Abscopal Anti-tumor Effect

Overview
Specialty Pharmacology
Date 2021 Feb 5
PMID 33545219
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Radiotherapy (RT)-induced DNA damage leaked into cytosol can elicit host antitumor immune response. However, such response rate is unpromising due to limited cyclic GMP-AMP synthase (cGAS) recognition of cytosolic DNA, which could be digested inherently by host DNases. Here we show that synchronizing Mn delivery with accumulated cytosolic DNA after RT can promote the activation of cGAS-STING pathway, thereby enhancing RT-induced antitumor immunity. Intratumoral Mn injection immediately after RT cannot enhance RT, while intratumoral Mn injection 24 h after RT can. Direct-injected Mn can be metabolized out from tumor in minutes while RT-induced DNA damage need cells mitotic progression for up to 24 h to accumulate into cytosol. Alginate can maintain Mn in tumor for up to 24 h due to it can chelate divalent cations. When the release profile of Mn is controlled by alginate (Alg) and synchronized with the accumulation of RT-induced DNA damage, over 90% inhibition rate can be obtained even in the unirradiated tumor, and survival time is significantly extended. This synchronizing strategy provides a simple and novel approach to effectively activate cGAS-STING pathway in tumor and promote RT-induced immunity.

Citing Articles

Targeting cGAS-STING pathway for reprogramming tumor-associated macrophages to enhance anti-tumor immunotherapy.

Zhang W, Huang X Biomark Res. 2025; 13(1):43.

PMID: 40075527 PMC: 11905658. DOI: 10.1186/s40364-025-00750-w.


Nanocarrier-mediated modulation of cGAS-STING signaling pathway to disrupt tumor microenvironment.

Pindiprolu S, Singh M, Magham S, Kumar C, Dasari N, Gummadi R Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 39907784 DOI: 10.1007/s00210-025-03835-3.


Tumor microenvironment-responsive and modulatory manganese-based nanoenzyme for enhanced tumor immunotherapy.

Yang Q, Wu Q, Liu H, Wu J, Ma F, Tian X Front Pharmacol. 2025; 15():1518983.

PMID: 39830353 PMC: 11739168. DOI: 10.3389/fphar.2024.1518983.


Biometallic ions and derivatives: a new direction for cancer immunotherapy.

Zhao L, Gui Y, Cai J, Deng X Mol Cancer. 2025; 24(1):17.

PMID: 39815289 PMC: 11734411. DOI: 10.1186/s12943-025-02225-w.


Identification of markers correlating with mitochondrial function in myocardial infarction by bioinformatics.

Kuang W, Huang J, Yang Y, Liao Y, Zhou Z, Liu Q PLoS One. 2025; 19(12):e0316463.

PMID: 39775580 PMC: 11684664. DOI: 10.1371/journal.pone.0316463.